Avalo Therapeutics (AVTX) Enterprise Value Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.34% |
| Dec 31, 2025 | -364.89% |
| Sep 30, 2025 | -264.34% |
| Jun 30, 2025 | -364.02% |
| Mar 31, 2025 | -53.29% |
| Dec 31, 2024 | -77.45% |
| Sep 30, 2024 | -280.81% |
| Jun 30, 2024 | -58.34% |
| Mar 31, 2024 | -46.87% |
| Dec 31, 2023 | 44.35% |
| Sep 30, 2023 | 51.44% |
| Jun 30, 2023 | 63.06% |
| Mar 31, 2023 | -45.90% |
| Dec 31, 2022 | 64.35% |
| Sep 30, 2022 | 6.69% |
| Jun 30, 2022 | -1.03% |
| Mar 31, 2022 | 49.36% |
| Dec 31, 2021 | -60.02% |
| Sep 30, 2021 | -51.99% |
| Jun 30, 2021 | -27.76% |
| Mar 31, 2021 | -18.19% |
| Dec 31, 2020 | 71.76% |
| Sep 30, 2020 | 47.49% |
| Jun 30, 2020 | 64.84% |
| Mar 31, 2020 | -11.28% |
| Dec 31, 2019 | 8.22% |
| Sep 30, 2019 | 63.48% |